/Revvity%20Inc_%20stock%20chart%20and%20logo-by%20T_Schneider%20via%20Shutterstock.jpg)
Waltham, Massachusetts-based Revvity, Inc. (RVTY) is a leading provider of health science solutions, offering advanced technologies, expertise, and services that encompass complete workflows from discovery and development to diagnosis and cure. Valued at $10.6 billion by market cap, Revvity serves customers across healthcare, academia, and governments, and employs over 11,000 people.
The healthcare major is set to announce its third-quarter results before the market opens on Monday, Oct. 27. Ahead of the event, analysts expect RVTY to report an adjusted earnings of $1.14 per share, down 10.9% from $1.28 per share reported in the year-ago quarter. On a positive note, the company has a robust earnings surprise history. It has surpassed the Street’s bottom-line estimates in each of the past four quarters.